Analyst Ratings For Amylyx Pharma
Analyst Ratings For Amylyx Pharma
Amylyx Pharma的分析师评级
Analysts' ratings for Amylyx Pharma (NASDAQ:AMLX) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
5位分析师提供的分析师对Amylyx Pharma（纳斯达克股票代码：AMLX）在上个季度的评级从看涨到看跌不等。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $6.2, a high estimate of $8.00, and a low estimate of $3.00. No alteration is observed as the current average remains at the previous average price target.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为6.2美元，最高估计为8.00美元，低估值为3.00美元。由于当前平均价格保持在先前的平均目标价，因此未观察到任何变化。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
In examining recent analyst actions, we gain insights into...
在研究分析师最近的...
登录免费看全文
登录/注册